Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9028 |
High Similarity |
NPD6190 |
Approved |
0.8403 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8397 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8217 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8089 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8049 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7959 |
Intermediate Similarity |
NPD943 |
Approved |
0.7935 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7925 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7925 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7914 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7823 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7806 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7786 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7738 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7736 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7673 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7657 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7632 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7484 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7471 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7419 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD919 |
Approved |
0.741 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7351 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7342 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7337 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7244 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7243 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7212 |
Intermediate Similarity |
NPD37 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7204 |
Intermediate Similarity |
NPD8319 |
Approved |
0.719 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7186 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7182 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7182 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7179 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7171 |
Intermediate Similarity |
NPD7095 |
Approved |
0.717 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7153 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1653 |
Approved |
0.707 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7065 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD9570 |
Approved |
0.702 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7018 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7016 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD7874 |
Approved |
0.6994 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD3146 |
Approved |
0.6993 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6987 |
Remote Similarity |
NPD1933 |
Approved |
0.6981 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6959 |
Remote Similarity |
NPD17 |
Approved |
0.6957 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD7038 |
Approved |
0.6949 |
Remote Similarity |
NPD7039 |
Approved |
0.6949 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6937 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6937 |
Remote Similarity |
NPD4534 |
Discontinued |
0.6928 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6923 |
Remote Similarity |
NPD826 |
Approved |
0.6923 |
Remote Similarity |
NPD825 |
Approved |
0.6919 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6919 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD2438 |
Suspended |
0.6914 |
Remote Similarity |
NPD2309 |
Approved |
0.6909 |
Remote Similarity |
NPD920 |
Approved |
0.6901 |
Remote Similarity |
NPD3022 |
Approved |
0.6901 |
Remote Similarity |
NPD3021 |
Approved |
0.6897 |
Remote Similarity |
NPD2629 |
Approved |
0.6897 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6878 |
Remote Similarity |
NPD7697 |
Approved |
0.6878 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6878 |
Remote Similarity |
NPD7698 |
Approved |
0.6875 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD7236 |
Approved |
0.6867 |
Remote Similarity |
NPD1201 |
Approved |
0.6864 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6863 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD3748 |
Approved |
0.6848
|
Remote Similarity |
NPD6273 |
Approved |